Global Vascular Access Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Device Type;
Central Vascular Access Devices [Peripherally Inserted Central Catheters, Tunneled Catheters, Percutaneous Non-Tunneled Catheters, Implanted Ports, and Others] and Peripheral Vascular Access Devices [Peripheral Catheter, Midline Catheter, and Others]By Application;
Administration of Drugs, Administration of Fluid & Nutrition, Diagnostics & Testing, and OthersBy End User;
Hospitals/Clinics, Diagnostic Centers, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Vascular Access Devices Market Overview
Vascular Access Devices Market (USD Million)
Vascular Access Devices Market was valued at USD 5,060.88 million in the year 2024. The size of this market is expected to increase to USD 8,020.94 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.8%.
Global Vascular Access Devices Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.8 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.8 % |
Market Size (2024) | USD 5,060.88 Million |
Market Size (2031) | USD 8,020.94 Million |
Market Concentration | Medium |
Report Pages | 394 |
Major Players
- Becton Dickinson
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Abbott
- Medtronic
- Teleflex
- AngioDynamics
- B. Braun Melsungen AG
- Smiths Medical
- Terumo Corporation
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Vascular Access Devices Market
Fragmented - Highly competitive market without dominant players
The Vascular Access Devices Market is witnessing robust momentum, largely due to the growing need for efficient delivery of intravenous medications and fluids. These devices are essential for patient management across emergency, surgical, and long-term care settings. Over 65% of hospitalized individuals require some form of vascular access, reflecting its widespread clinical integration.
Shift Toward Minimally Invasive Techniques
There is a rising preference for minimally invasive vascular access techniques, driven by improved patient outcomes and procedural efficiency. Approximately 55% of vascular access insertions now use image-guided or less-invasive technologies. This shift not only enhances procedural success but also minimizes discomfort and recovery time.
Demand Fueled by Chronic Care Requirements
With the global burden of chronic illnesses on the rise, particularly in cancer and renal care, the demand for durable vascular access solutions has intensified. Over 60% of oncology infusions and nearly 45% of dialysis treatments now utilize these devices, affirming their role in long-term therapy delivery.
Clinical Training and Standardization Benefits
Enhanced awareness among healthcare professionals and the availability of structured training programs have improved the safe use of vascular access Devices. As a result, there has been a notable 30% drop in insertion-related complications, indicating the success of standardization and best practice implementation across clinical environments.
Vascular Access Devices Market Recent Developments
-
In September 2024, B. Braun secured FDA 510(k) clearance for its next-gen Introcan Safety 2 Deep Access IV Catheter, expanding the safe and reliable Introcan Safety 2 range.
-
In January 2025, Vygon issued a recall for a defective batch of its Lifecath PICC, underscoring heightened regulatory focus and commitment to patient safety in vascular access care.
Vascular Access Devices Market Segment Analysis
In this report, the Vascular Access Devices Market has been segmented by Device Type, Application, End User and Geography.
Vascular Access Devices Market, Segmentation by Device Type
The Vascular Access Devices Market has been segmented by Device Type into Central Vascular Access Devices [Peripherally Inserted Central Catheters, Tunneled Catheters, Percutaneous Non-Tunneled Catheters, Implanted Ports, and Others] and Peripheral Vascular Access Devices [Peripheral Catheter, Midline Catheter, and Others]
Central Vascular Access Devices
Central vascular access devices are inserted into large veins and used for long-term therapies. This segment includes peripherally inserted central catheters (PICCs), tunneled catheters, percutaneous non-tunneled catheters, implanted ports, and others. These devices represent about 60% of the market, primarily driven by demand in oncology, intensive care, and chronic disease management.
Peripheral Vascular Access Devices
Peripheral vascular access devices are used for short-term intravenous therapies and are less invasive. The category includes peripheral catheters, midline catheters, and others. Holding roughly 40% of the market share, these devices are widely adopted in emergency care and ambulatory settings.
Vascular Access Devices Market, Segmentation by Application
The Vascular Access Devices Market has been segmented by Application into Administration of Drugs, Administration of Fluid and Nutrition, Diagnotics and Testing and Others.
Administration of Drugs
The administration of drugs is a primary application of vascular access devices, accounting for approximately 40% of the market share in 2023. These devices are essential for delivering medications such as antibiotics and chemotherapy agents, especially in patients requiring long-term treatment. Their ability to provide reliable and repeated access to the bloodstream enhances treatment efficiency and patient comfort.
Administration of Fluid and Nutrition
Vascular access devices play a crucial role in the administration of fluids and nutritional support, particularly for patients unable to consume food orally. They facilitate the delivery of parenteral nutrition and hydration therapy, ensuring patients receive essential nutrients and fluids. This application is vital in managing patients with gastrointestinal disorders, critical illnesses, or those undergoing major surgeries
Diagnostics and Testing
In diagnostics and testing, vascular access devices are employed for blood sampling and the administration of contrast agents during imaging procedures. They enable accurate and timely diagnostic evaluations, reducing the need for multiple needle insertions. This application enhances patient experience and supports efficient clinical workflow
Others
Beyond the primary applications, vascular access devices are utilized in various other medical procedures, including blood transfusions, dialysis, and stem cell transplantation. Their versatility and adaptability make them indispensable tools in comprehensive patient care across diverse medical specialtie
Vascular Access Devices Market, Segmentation by End User
The Vascular Access Devices Market has been segmented by End User into Hospitals/Clinics, Diagnostic Centers and Others.
Hospitals/Clinics
Hospitals and clinics are the primary end-users of vascular access devices, accounting for approximately 50.2% of the market share in 2024. The dominance of this segment is attributed to the availability of skilled healthcare professionals and advanced medical infrastructure that facilitate the effective use of these devices. The increasing prevalence of chronic diseases and the rising number of hospital admissions for treatments like chemotherapy and dialysis further drive the demand in this segment
Diagnostic Centers
Diagnostic centers are emerging as significant end-users in the vascular access devices market. The growing demand for minimally invasive procedures and the need for efficient blood sampling techniques contribute to the adoption of these devices in diagnostic settings. Additionally, the expansion of point-of-care testing and outpatient diagnostic services supports the growth of this segment
Others
The 'Others' category encompasses various healthcare settings such as ambulatory surgical centers, home healthcare, and long-term care facilities. The increasing preference for home-based treatments and the rise in ambulatory care services have led to a higher adoption of vascular access devices in these settings. These environments benefit from the convenience and cost-effectiveness offered by such devices, especially for patients requiring long-term intravenous therapies
Vascular Access Devices Market, Segmentation by Geography
In this report, them Vascular Access Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Vascular Access Devices Market Share (%), by Geographical Region
North America
North America dominated the vascular access devices market in 2023, accounting for approximately 58.5% of the total market share. This dominance is attributed to the high prevalence of chronic diseases such as cardiovascular conditions and chronic kidney disease, which necessitate the use of vascular access devices. Additionally, the presence of advanced healthcare infrastructure and leading medical device manufacturers further propels market growth in this region
Europe
Europe holds a significant share in the vascular access devices market, driven by a growing aging population and a high incidence of chronic illnesses requiring long-term treatments. Countries like Germany, the UK, and France are leading contributors, owing to their robust healthcare systems and increased healthcare expenditure. The demand for minimally invasive procedures and advanced medical technologies further supports market expansion in this region
Asia Pacific
The Asia Pacific region is anticipated to witness the fastest growth in the vascular access devices market during the forecast period. Factors such as a rising geriatric population, increasing prevalence of chronic diseases, and improving healthcare infrastructure in countries like China, India, and Japan contribute to this growth. Moreover, government initiatives aimed at enhancing healthcare accessibility and affordability are expected to boost market demand
Middle East and Africa
The vascular access devices market in the Middle East and Africa is emerging, with growth driven by the increasing burden of non-communicable diseases and efforts to improve healthcare services. Countries like Saudi Arabia and the UAE are investing in healthcare infrastructure and adopting advanced medical technologies to meet the rising demand for quality healthcare, thereby fostering market growth
Latin America
Latin America is experiencing steady growth in the vascular access devices market, supported by an increasing prevalence of chronic conditions and efforts to enhance healthcare delivery. Countries such as Brazil and Mexico are focusing on expanding public health initiatives and improving medical facilities, which in turn is expected to drive the adoption of vascular access devices in the region
Vascular Access Devices Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Vascular Access Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
---|---|---|---|---|---|
Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Rising prevalence of chronic diseases
- Increasing number of surgeries and hospitalizations
- Shift toward minimally invasive and ultrasound-guided techniques
-
Expanding home infusion and ambulatory care models - The rapid growth of home infusion and ambulatory care models is a major driver of the Vascular Access Devices Market, as healthcare systems worldwide shift toward more cost-effective, patient-centered care. With rising pressure to reduce hospital stays and overall treatment costs, home-based therapies for conditions such as infections, cancer, and chronic diseases are becoming increasingly popular. These care models rely heavily on vascular access devices like peripherally inserted central catheters (PICCs), midlines, and ports to safely deliver long-term medication and fluids outside traditional hospital settings. This trend not only improves patient comfort and convenience but also reduces the burden on inpatient facilities.
Additionally, the expansion of ambulatory surgical centers and outpatient clinics has increased the demand for reliable and easy-to-use vascular access solutions. These settings require devices that minimize the risk of infection, reduce the need for repeated insertions, and support rapid treatment initiation. Technological advancements in catheter materials, antimicrobial coatings, and insertion techniques are further enhancing device performance and safety, making them more suitable for use in decentralized healthcare environments. As the demand for accessible, flexible treatment options continues to grow, the vascular access devices market is expected to experience sustained momentum driven by this care model transformation.
Restraints
- Risk of infections, such as CRBSIs and phlebitis
- Occurrence of thrombosis or catheter occlusion, impacting device performance
- Stringent regulatory requirements and lengthy approvals
-
Shortage of skilled professionals to ensure safe - The ongoing shortage of skilled professionals to ensure safe use and placement of vascular access devices is a notable restraint in the Vascular Access Devices Market. These devices require precise insertion techniques and careful handling to prevent complications such as infection, thrombosis, or device malfunction. However, many healthcare facilities, particularly in rural and under-resourced regions, face a lack of adequately trained nurses, technicians, and physicians who specialize in vascular access. This gap in expertise can lead to improper device placement, increased patient risk, and a higher rate of treatment failures, undermining the effectiveness of these technologies.
The demand for vascular access is growing in home care, ambulatory settings, and critical care environments, further straining the need for skilled professionals. Without consistent training and certification programs, many care providers may not be equipped to maintain best practices in device insertion and management. This not only affects patient outcomes but also limits the widespread adoption of advanced vascular access solutions. Addressing this restraint will require coordinated efforts to expand training programs, improve clinical education, and ensure competency among healthcare personnel to fully realize the benefits of vascular access devices across diverse care settings.
Opportunities
- Surge in medical tourism and middle-class healthcare access
- Broader clinical applications in oncology, nephrology, critical care
-
Expansion of home healthcare and ambulatory care services - The continued expansion of home healthcare and ambulatory care services offers a major opportunity for the Vascular Access Devices Market. As healthcare delivery shifts away from traditional hospital settings, there is growing demand for reliable, safe, and easy-to-use vascular access devices to support treatments such as intravenous therapy, chemotherapy, and parenteral nutrition in outpatient and home environments. Patients with chronic illnesses and post-operative needs are increasingly managed in these settings, driving the adoption of devices like PICCs, midlines, and ports that facilitate long-term therapy while minimizing hospital visits.
This transition is being fueled by rising healthcare costs, an aging population, and a strong focus on patient-centric care. Vascular access devices play a critical role in enabling effective care delivery outside of hospitals by ensuring consistent, sterile, and secure access to the vascular system. Additionally, innovations in device design, antimicrobial technology, and remote monitoring are enhancing usability and safety, making them more compatible with decentralized care models. As home healthcare and ambulatory services continue to expand globally, they are expected to create substantial growth avenues for vascular access device manufacturers and providers.
Vascular Access Devices Market Competitive Landscape Analysis
Key players in Vascular Access Devices Market include:
- Becton Dickinson
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Abbott
- Medtronic
- Teleflex
- AngioDynamics
- B. Braun Melsungen AG
- Smiths Medical
- Terumo Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Vascular Access Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Rising prevalence of chronic diseases
-
Increasing number of surgeries and hospitalizations
-
Shift toward minimally invasive and ultrasound-guided techniques
-
Expanding home infusion and ambulatory care models
-
Risk of infections, such as CRBSIs and phlebitis
-
Occurrence of thrombosis or catheter occlusion, impacting device performance
-
Stringent regulatory requirements and lengthy approvals
-
Shortage of skilled professionals to ensure safe
-
- Opportunities
-
Surge in medical tourism and middle-class healthcare access
-
Broader clinical applications in oncology, nephrology, critical care
-
Expansion of home healthcare and ambulatory care services
-
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Drivers
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Vascular Access Devices Market, By Device Type, 2021 - 2031 (USD Million)
- Central Vascular Access Devices
- Peripherally Inserted Central Catheters
- Tunneled Catheters
- Percutaneous Non-Tunneled Catheters
- Implanted Ports
- Others
- Peripheral Vascular Access Devices
- Peripheral Catheter
- Midline Catheter
- Others
- Central Vascular Access Devices
- Vascular Access Devices Market, By Application, 2021 - 2031 (USD Million)
- Administration of Drugs
- Administration of Fluid and Nutrition
- Diagnotics and Testing
- Others
- Vascular Access Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals/Clinics
- Diagnostic Centers
- Others
- Vascular Access Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Vascular Access Devices Market, By Device Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Becton Dickinson
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Abbott
- Medtronic
- Teleflex
- AngioDynamics
- B. Braun Melsungen AG
- Smiths Medical
- Terumo Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market